Primient, a leader in plant-based, renewable ingredients, and Synonym, a developer of biomanufacturing infrastructure, have announced a strategic partnership aimed at accelerating bioproduct innovation and commercialization in the U.S. This collaboration is set to enhance the country’s competitive edge by advancing the development of functional and affordable biomaterials. The combined expertise, technologies, and assets of both companies are poised to fast-track the delivery of next-generation bioproduct solutions and materials.
The partnership will harness Primient’s extensive experience in the bioproduct space and Synonym’s robust biomanufacturing infrastructure to support the transition of new product concepts from the lab to commercial scale.
Primient – Over a Century of Pioneering Renewable, Plant-Based Solutions
With over a century of experience, Primient has established itself as a pioneer in the agri-business sector, excelling in bioproducts and manufacturing leadership across food and industrial ingredients, as well as fermentation processes from feedstock to finished product.
Jim Stutelberg, CEO of Primient, commented, “We are one of the original players in this field, fully recognizing the potential of biobased products. Our partnership with Synonym will significantly advance efforts to scale biobased solutions, offering a data-driven proving ground for growth and support. We are enthusiastic about this collaboration and the positive impact we expect to achieve together.”
Synonym – Revolutionizing the Scale-Up Process for New Compounds
Synonym is known for its innovative platforms and products that facilitate the commercialization journey for companies. Its data-driven and collaborative approach, along with a comprehensive portfolio of solutions, supports businesses across various industries in bringing bioproducts to market.
Edward Shenderovich, CEO of Synonym, stated, “Our digital tools have been utilized by thousands in the precision fermentation sector, and we are aware of the challenges involved in scaling bioproducts. By integrating our development and financing expertise with Primient’s manufacturing capabilities, we are enabling a smooth transition from concept to commercialization. We look forward to seeing the impact of this partnership in the coming months.”
Inaugural Project
The first project under this partnership will be based at Primient’s facility in Decatur, IL. The initial efforts will focus on re-commissioning and upgrading existing fermentation assets, expanding current capacity, and significantly enhancing the downstream processing unit.
Upon completion, the joint Primient-Synonym facility will offer a comprehensive range of services to support companies using precision fermentation, facilitating the transition of new product concepts from the lab to full commercial scale.
